Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

NCT04944368 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
BIOLOGICAL: Saline placebo

Sponsor

Cinnagen

Collaborators

[object Object]